Results 71 to 80 of about 75,416 (289)

Impact of Elective Percutaneous Coronary Intervention on Improvement of Ischemic Mitral Regurgitation

open access: yesMajallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Shahīd Ṣadūqī Yazd, 2018
Introdution: Ischemic mitral regurgitation (IMR) remains one of the most complex and unresolved aspects of ischemic heart disease that the impact of percutaneous coronary intervention (PCI) on improvement of intensity of ischemic mitral regurgitation is ...
Hakimeh Sadeghian   +7 more
doaj  

Septal Myectomy without Correction of Moderate and Severe Mitral Regurgitation [PDF]

open access: yes
Objectives: Septal myectomy (SM) is the gold standard treatment option for patients with hypertrophic obstructive cardiomyopathy (HOCM) whose symptoms do not respond to medical therapy. Extended SM adequately relieves left ventricular outflow tract (LVOT)
Vizil Desai   +2 more
core   +1 more source

Prognostic role of TAPSE to PASP ratio in outpatients with left ventricular systolic dysfunction

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 912-922, April 2025.
Abstract Aims Few data are available regarding the role of tricuspid annulus plane systolic excursion to pulmonary artery systolic pressure (TAPSE/PASP), a measurement of right ventricular to pulmonary artery coupling, in patients with chronic heart failure and left ventricular systolic dysfunction.
Mauro Riccardi   +9 more
wiley   +1 more source

Simultaneous implantation of MitraClip devices in a patient with severe mitral and tricuspid valve regurgitation

open access: yesHellenic Journal of Cardiology, 2019
We present a case of an 84-year old patient with severe mitral and tricuspid regurgitation with a lot of cormobidities who underwent a simultaneous transfemoral (one approach) mitral and tricuspid valve repair using the MitraClip system.
Vlasis Ninios   +7 more
doaj   +1 more source

Left atrial function in uraemic patients: Four‐dimensional automatic left atrial quantitative technology study

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1316-1325, April 2025.
Abstract Objective This study aimed to evaluate the utility of left atrial volume and function in uraemic patients using four‐dimensional automatic left atrial quantification (4D auto LAQ) technology. Methods Thirty‐four undialysed uraemic patients (U‐ND group), 60 dialysed uraemic patients (U‐D group), and 32 healthy volunteers (N group) were enrolled
Bing Li, Meihua Chen, Xuning Huang
wiley   +1 more source

Effect of physiological overload on pregnancy in women with mitral regurgitation

open access: yesClinics, 2011
OBJECTIVES: to evaluate the structural and functional heart abnormalities in women with mitral regurgitation during pregnancy. INTRODUCTION: Women with mitral regurgitation progress well during pregnancy.
Vera T. M Borges   +4 more
doaj  

Impact of Mitral Surgery for Mitral Regurgitation on Coexisting Aortic Regurgitation

open access: yesAnnals of Thoracic and Cardiovascular Surgery, 2020
There is no clear finding on the course of coexisting aortic regurgitation (AR) after treatment of mitral regurgitation (MR). We investigated the effect of mitral surgery for MR on coexisting AR.Between January 2008 and December 2016, 75 patients underwent mitral surgery for MR coexisting mild AR.
Hachiro, Kohei   +3 more
openaire   +3 more sources

Mitral regurgitation: challenges and solutions

open access: yes, 2016
Julius I Ejiofor, Lawrence Cohn,† Tsuyoshi Kaneko Division of Cardiac Surgery, Brigham and Women’s Hospital, Boston, MA, USA †Lawrence Cohn passed away on January 9, 2016 Abstract: Since the first mitral valvuloplasty in 1923, the ...
Ejiofor JI, Kaneko T, Cohn L
core  

Short-term Clinical Outcomes of Transcatheter Edge-to-edge Repair using MitraClip for Mitral Regurgitation : Experience from a Single Center [PDF]

open access: yes
Background : As the first commercially available device to treat mitral regurgitation (MR) percutaneously, the MitraClip transcatheter edge-to-edge repair (TEER) system was approved for use in Japan in 2017.
Sunohara, Daisuke   +10 more
core   +1 more source

Exercise limitations in amyloid cardiomyopathy assessed by cardiopulmonary exercise testing—A multicentre study

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1326-1335, April 2025.
Abstract Aims Amyloid cardiomyopathy is caused by the deposition of light chain (AL) or transthyretin amyloid (ATTR) fibrils, that leads to a restrictive cardiomyopathy, often resulting in heart failure (HF) with preserved or reduced ejection fraction.
Robin Willixhofer   +25 more
wiley   +1 more source

Home - About - Disclaimer - Privacy